Oxygen treatment reduces neurological deficits and demyelination in two animal models of multiple sclerosis.

Publication Year: 2023

DOI:
10.1111/nan.12868

PMCID:
PMC10107096

PMID:
36520661

Journal Information

Full Title: Neuropathol Appl Neurobiol

Abbreviation: Neuropathol Appl Neurobiol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST The authors have no conflicts of interest to disclose."

Evidence found in paper:

"This work was supported by grant funding to KJS from the Medical Research Council (MRC), the UK Multiple Sclerosis Society, the National Multiple Sclerosis Society, the Rosetrees Trust and the Fondation Leducq."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025